These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis. Patterson R; Miller M; Kaplan M; Doan T; Brown J; Detjen P; Grammer LC; Greenberger PA; Hogan MB; Latall J Ann Allergy; 1994 Jul; 73(1):27-34. PubMed ID: 8030799 [TBL] [Abstract][Full Text] [Related]
6. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides]. Aberer W; Stingl G; Wolff K Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320 [TBL] [Abstract][Full Text] [Related]
7. [Drug-induced Stevens-Johnson syndrome in a patient with AIDS]. Schlienger RG; Haefeli WE; Bircher A; Leib SL; Lüscher TF Schweiz Rundsch Med Prax; 1993 Aug; 82(33):888-92. PubMed ID: 8372290 [TBL] [Abstract][Full Text] [Related]
8. [Occurrence of the Stevens-Johnson syndrome (erythema exudativum multiforme) and severe skin reactions with relation to sulfonamide therapy. Reply to questions sent to a Norwegian hospital]. Tidsskr Nor Laegeforen; 1966 Sep; 86(17):1207-9. PubMed ID: 4224656 [No Abstract] [Full Text] [Related]
10. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164 [TBL] [Abstract][Full Text] [Related]
11. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective. Mockenhaupt M; Kelly JP; Kaufman D; Stern RS; J Rheumatol; 2003 Oct; 30(10):2234-40. PubMed ID: 14528522 [TBL] [Abstract][Full Text] [Related]
12. [Comparative study of Lyell's and Stevens-Johnson syndromes: etiological role of drugs]. Monnat A Schweiz Med Wochenschr; 1972 Dec; 102(52):1906-11. PubMed ID: 4660388 [No Abstract] [Full Text] [Related]
13. A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures. Strom BL; Carson JL; Halpern AC; Schinnar R; Snyder ES; Shaw M; Tilson HH; Joseph M; Dai WS; Chen D Arch Dermatol; 1991 Jun; 127(6):831-8. PubMed ID: 2036028 [TBL] [Abstract][Full Text] [Related]
15. Ophthalmic complications and management of Stevens-Johnson syndrome at a tertiary eye care centre in south India. Kompella VB; Sangwan VS; Bansal AK; Garg P; Aasuri MK; Rao GN Indian J Ophthalmol; 2002 Dec; 50(4):283-6. PubMed ID: 12532492 [TBL] [Abstract][Full Text] [Related]
16. Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection. Porteous DM; Berger TG Arch Dermatol; 1991 May; 127(5):740-1. PubMed ID: 1827245 [No Abstract] [Full Text] [Related]
17. Human immunodeficiency virus, pregnancy, and Stevens-Johnson syndrome. Shilad A; Predanic M; Perni SC; Houlihan C; Principe D Obstet Gynecol; 2005 May; 105(5 Pt 2):1254-6. PubMed ID: 15863600 [TBL] [Abstract][Full Text] [Related]
18. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study. Lin MS; Dai YS; Pwu RF; Chen YH; Chang NC Intern Med J; 2005 Mar; 35(3):188-90. PubMed ID: 15737140 [TBL] [Abstract][Full Text] [Related]
19. [Drugs as an etiological factor in the Stevens-Johnson's syndrome]. Rev Clin Esp; 1969 Jan; 112(1):99-100. PubMed ID: 5766961 [No Abstract] [Full Text] [Related]